Degenerative Disc Disease Market Expected to Rise at a Moderate Growth Rate by (2022-2032) – Assessed by DelveInsight | Key Companies – Mesoblast/Gruenthal, Stayble Therapeutics

0

The degenerative disc disease market is expected to rise owing to the growing prevalence and awareness of the disease over the forecast period. In addition, the launch of various multi-stage degenerative disc disease pipeline products will significantly revolutionize the dynamics of the degenerative disc disease market.

by DelveInsight “Degenerative Disc Disease Market Insights, Epidemiology and Forecast-2032” The report offers an in-depth understanding of degenerative disc disease, historical and forecast epidemiology as well as degenerative disc disease market trends in the US, EU5 (Germany, Spain, Italy, France and UK) and in Japan.

The Degenerative Disc Disease Market report covers emerging drugs, current treatment practices, individual therapies market share, and current and forecasted market size from 2019 to 2032. It also assesses the practice/algorithm treatment options, market drivers and barriers, and unmet medical issues. must select the best opportunities and assess the underlying market potential.

To know in detail the Degenerative Disc Disease market outlook, drug consumption, treatment scenario and epidemiological trends, click here; Degenerative Disc Disease Market Overview

Overview of Degenerative Disc Disease

Degenerative disc disease (DDD) is a common disease characterized by progressive degeneration of the intervertebral disc; making them deformed and mechanically dysfunctional. It is a catch-all phrase for a number of structural changes in the spine, such as loss of disc height, disc bulges, hydration, and impingement of spinal nerves, among others. .

Some of the key facts from the Degenerative Disc Disease Market report:

  • Degenerative disc disease market size is expected to grow with significant growth CAGR during the study period (2019-2032)
  • Chronic low back pain (CLBP) affects approximately 10-15% of the adult population, i.e. more than 30 million people in the United States and nearly 40 million people in the EU5
  • According to the study conducted by Teraguchi et al., the prevalence of intervertebral disc (DD) degeneration across the entire spine was 71% in men and 77% in older women 90% in older men and women >50 years
  • Key Degenerative Disc Disease Companies: Mesoblast/Gruenthal, Stayble Therapeutics, Kuros Biosciences, DiscGenics, Ankasa Therapeutics, AnGes and others
  • Key therapies for degenerative disc disease: Rexlemestrocel, STA363, fibrin-PTH (KUR-113), IDCT (rebonuputemcel), ART352-L, AMG0103 and others
  • Sex-based epidemiology of degenerative disc disease analyzed that women are more often affected by degenerative disc disease

Get Free Sample For Degenerative Disc Disease Market Report

https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr

Key points of the Degenerative Disc Disease Market report:

  1. The Degenerative Disc Disease Market report covers a descriptive overview and comprehensive overview of the epidemiology of Degenerative Disc Disease and Degenerative Disc Disease market in 7MM (US, EU5 (Germany, Spain, France, Italy, UK) and Japan.)
  2. The Degenerative Disc Disease market report provides information on current and emerging therapies.
  3. The Degenerative Disc Disease market report provides historical and forecast global market covering the spread of drugs in 7MM.
  4. The Degenerative Disc Disease Market report offers an advantage which will help in developing business strategies by understanding the trends shaping and driving the Degenerative Disc Disease market.

Download the report to understand which factors drive epidemiological trends in degenerative disc disease @ Epidemiological Overview of Degenerative Disc Disease

Degenerative Disc Disease Market

The dynamics of the degenerative disc disease market are expected to change in the coming years owing to the expected launch of emerging and other therapies during the forecast period 2019-2032.

“Key players, such as DiscGenics, mesoblast, Kuros Biosciences are involved in the development of therapies for degenerative disc disease. The expected launch of emerging therapies, such as IDCT, Rexlemestrocel, Fibrin-PTH (KUR-113) and other treatments, would result in a significant increase in the market size over the forecast period.

Epidemiology of degenerative disc disease

The epidemiology section provides an overview of historical, current and projected epidemiological trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and projected trends by exploring numerous studies and viewpoints from world leaders. key opinion. The epidemiology section also provides a detailed analysis of the pool of diagnosed patients and future trends.

Segmentation of degenerative disc disease epidemiology:

The Degenerative Disc Disease Market report offers epidemiological analysis for the study period 2019-2032 in 7MM segmented into:

  • Total prevalence of degenerative disc disease
  • Prevalent cases of degenerative disc disease by severity
  • Prevalence by sex of degenerative disc disease
  • Diagnosed cases of episodic and chronic degenerative disc disease

Degenerative Disc Disease Drug Adoption and Pipeline Development Activities

The drug uptake section focuses on the uptake rate of potential drugs recently launched in the degenerative disc disease market or expected to be launched during the study period. The analysis covers degenerative disc disease market uptake by drugs, patient uptake of therapies, and sales of each drug.

In addition, the therapeutic evaluation section helps to understand which drugs are absorbed the fastest and the reasons for the maximum use of drugs. Moreover, it compares drugs based on their market share.

The report also covers Degenerative Disc Disease pipeline development activities. It provides valuable information on different therapeutic candidates at various stages and on the main companies involved in the development of targeted therapies. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details and other information on emerging therapies.

Learn More About Therapies Set to Capture Major Degenerative Disc Disease Market Share @ Degenerative Disc Disease Market Forecast

Degenerative disc disease therapies and key companies

  • Rexlemestrocel: Mesoblast/Gruenthal
  • STA363: Stayble Therapeutic
  • Fibrin-PTH (KUR-113): Kuros Biosciences
  • IDCT(rebonuputemcel): DiscGenics
  • ART352-L: Therapeutic Ankasa
  • AMG0103: AnGès

Degenerative Disc Disease Market Drivers

  • Rich Emerging Degenerative Disc Disease Pipeline
  • Increase in the prevalence of degenerative disc disease
  • Advances in the understanding of diseases

Scope of the Degenerative Disc Disease Market Report

  • Study period: 2019-2032
  • Cover: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Degenerative Disc Disease Companies: Mesoblast/Gruenthal, Stayble Therapeutics, Kuros Biosciences, DiscGenics, Ankasa Therapeutics, AnGes and others
  • Key therapies for degenerative disc disease: Rexlemestrocel, STA363, fibrin-PTH (KUR-113), IDCT (rebonuputemcel), ART352-L, AMG0103 and others
  • Therapeutic assessment of degenerative disc disease: Currently marketed treatments for degenerative disc disease and emerging therapies for degenerative disc disease
  • Degenerative Disc Disease Market Dynamics: Degenerative Disc Disease Market Drivers and Degenerative Disc Disease Market Barriers
  • Competitive intelligence analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG matrix, market entry strategies
  • Degenerative Disc Disease Unmet Needs, KOL Viewpoints, Analyst Views, Degenerative Disc Disease Market Access and Reimbursement

Degenerative Disc Disease Market Barriers

  • Impact on the patient’s quality of life
  • Failure to recognize the condition delays the start of more appropriate care

Contents

1. Overview of the Degenerative Disc Disease Market Report

2. Executive Summary for Degenerative Disc Disease

3. SWOT Analysis of Degenerative Disc Disease

4. Share of Patients with Degenerative Disc Disease (%) Overview at a Glance

5. Degenerative Disc Disease Market Overview at a Glance

6. Background and overview of degenerative disc disease

7. Degenerative disc disease epidemiology and patient population

8. Patient Population by Countries with Degenerative Disc Disease

9. Current Degenerative Disc Disease Treatment and Medical Practices

10. Unmet Needs of Degenerative Disc Disease

11. Emerging therapies for degenerative disc disease

12. Degenerative Disc Disease Market Outlook

13. Degenerative Disc Disease Market Analysis by Countries (2019-2032)

14. Access to the degenerative disc disease market and reimbursement of therapies

15. Degenerative Disc Disease Market Drivers

16. Degenerative Disc Disease Market Barriers

17. Annex on degenerative disc disease

18. Degenerative Disc Disease Report Methodology

19. DelveInsight Abilities

20. Disclaimer

21. About DelveInsight

To learn more about Degenerative Disc Disease Treatment, visit @ Degenerative Disc Disease Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Gaurav Bora
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Share.

About Author

Comments are closed.